Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
---|
11/19/1992 | EP0513921A2 Recombinant vaccine against Marek's disease |
11/19/1992 | EP0513090A1 Hepatitis a vaccines |
11/18/1992 | CA2068817A1 Vaccines and methods for their production |
11/12/1992 | WO1992019748A1 Herpesvirus particles and vaccine |
11/12/1992 | WO1992019268A1 New hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines |
11/12/1992 | WO1992019266A1 Recombinant virus expressing carcinoembryonic antigen and methods of use thereof |
11/10/1992 | US5162222 Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses |
11/10/1992 | US5162112 Influenza vaccine |
11/09/1992 | WO1992019267A1 Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them |
11/04/1992 | EP0511311A1 Novel retroviral vectors |
11/02/1992 | WO1992019725A1 Human rotavirus hcr3, reassortants thereof and vaccine compositions containing them |
11/02/1992 | CA2085597A1 Human rotavirus hcr3, reassortants thereof and vaccine compositions containing them |
10/29/1992 | WO1992018619A1 Heterodimeric receptor libraries using phagemids |
10/29/1992 | WO1992018616A1 Novel reference influenza viruses and antiviral drug susceptibility methods |
10/28/1992 | EP0510996A1 Recombinant varicella-zoster virus vector |
10/28/1992 | EP0510907A2 Bacteriophage lysins and their applications in destroying and testing for bacteria |
10/28/1992 | EP0510773A1 Canine coronavirus subunit vaccine |
10/28/1992 | CN1065681A Cell ablation using trans-splicing ribozymes |
10/28/1992 | CN1018845B 病毒疫苗 Virus vaccine |
10/27/1992 | WO1992001801A1 Modified baculovirus, method for obtaining it, and expression vectors obtained from said baculovirus |
10/22/1992 | DE4112952A1 New DNA encoding fusion protein contg. M13 alpha fragment |
10/21/1992 | EP0509008A1 Biomass for the production of viruses/virus antigens. |
10/21/1992 | CA2395688A1 Viral products |
10/20/1992 | WO1992018618A1 Modified plant viruses as vectors |
10/20/1992 | US5156957 Transformed mammalian cell containing an expression vector which is capable of producing a heterodimeric human fertility hormone coded by a distinct RNA |
10/20/1992 | US5156949 Immunoassays for antibody to human immunodeficiency virus using recombinant antigens |
10/14/1992 | EP0508809A1 Proteinaceous lipid-containing particles |
10/14/1992 | EP0508783A1 Attenuated poliovirus and vaccines thereof |
10/14/1992 | CN1065293A Entomopoxvirus expression system |
10/13/1992 | CA1308651C Testing for the human b lymphotropic virus (hblv) |
10/11/1992 | WO1992018621A1 Proteinaceous lipid-containing particles |
10/11/1992 | WO1992018620A1 Attenuated poliovirus and vaccines thereof |
10/11/1992 | CA2108141A1 Attenuated poliovirus and vaccines thereof |
10/11/1992 | CA2107879A1 Proteinaceous lipid-containing particles |
10/11/1992 | CA2042318A1 Attenuated viruses |
10/07/1992 | EP0507179A2 Equine herpes viruses (EHV) containing foreign DNA, process for their preparation and their use as vaccines |
10/07/1992 | EP0506945A1 Method of gene transfer using retrotransposons |
10/07/1992 | EP0506714A1 Matrix with adherently bound cells and process for producing viruses/virus antigens. |
10/01/1992 | WO1992016638A1 Transduction vehicles for transferring dna to a mammalian cell |
10/01/1992 | WO1992016637A1 Biological control agents |
10/01/1992 | WO1992016616A1 Malaria recombinant poxvirus vaccine |
10/01/1992 | CA2106587A1 Biological control agents |
10/01/1992 | CA2106464A1 Malaria recombinant poxvirus vaccine |
09/30/1992 | WO1992017570A1 Virus inactivation method and pharmaceutical composition therefor |
09/30/1992 | EP0506147A2 Canine distemper virus vaccine |
09/30/1992 | CA2107092A1 Virus inactivation method and pharmaceutical composition therefor |
09/29/1992 | US5151499 Virus deactivated protein from plasma |
09/29/1992 | US5151023 Hepatitis a,b-combined adjuvanted vaccine |
09/23/1992 | EP0505207A1 Biological control agents |
09/22/1992 | US5149653 By freeze-drying or drying in presence of stabilizer trehalose storage stability; used as immunogenic vaccines |
09/22/1992 | US5149530 Live newcastle disease virus vaccines |
09/17/1992 | WO1992015677A1 Process for the development of binding mini-proteins |
09/17/1992 | WO1992015672A1 Genetically engineered vaccine strain |
09/17/1992 | WO1992015605A2 Inhibitors of human neutrophil elastase and human cathepsin g |
09/17/1992 | WO1992015328A1 Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof |
09/17/1992 | WO1992015325A1 Solomon islands variants of human t-lymphotropic virus |
09/16/1992 | EP0502927A1 Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
09/16/1992 | CN1064409A 无细胞马立克氏病病毒疫苗 Marek's disease virus acellular vaccine |
09/15/1992 | US5147788 Baculovirus vectors and methods of use |
09/15/1992 | US5147639 Type-c rotavirus cultures and uses therefor |
09/09/1992 | EP0502146A1 MAREK'S DISEASE HERPESVIRUS DNA SEGMENT ENCODING GLYCOPROTEIN gE |
09/02/1992 | WO1992015679A1 Improved epitode displaying phage |
09/02/1992 | EP0500893A1 Preservation of blood, tissues and biological fluids |
09/02/1992 | CA2105303A1 Display phage |
09/01/1992 | CA1306951C Regulating retroviral replication, infection, and pathogenesis |
08/26/1992 | EP0500311A2 Biologically active bacillus thuringiensis isolates and gene encoding a cleopteran-active toxin |
08/25/1992 | US5142032 Human papillomavirus type 41 dna |
08/25/1992 | CA1306671C Bacteriophage prevention and control of harmful plant bacteria |
08/20/1992 | WO1992014829A1 Viral particles having altered host range |
08/20/1992 | WO1992014818A2 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences |
08/20/1992 | WO1992013943A1 Herpes simplex virus-1 deletion variants and vaccines thereof |
08/20/1992 | WO1992013882A1 Synthetic peptides suitable to enhance hiv-1 virus infectivity |
08/20/1992 | CA2103550A1 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences |
08/18/1992 | US5139947 Antigenic noninfectious hiv-producing cloned t cell |
08/18/1992 | CA1306431C Nucleic acid probes for prenatal sexing |
08/12/1992 | EP0497922A1 Infective protein delivery system |
08/12/1992 | EP0160699B1 Production of heterodimeric human fertlity hormones |
08/06/1992 | WO1992013089A1 Cell ablation using trans-splicing ribozymes |
08/05/1992 | EP0496875A1 METHODS FOR PRODUCING RNA VIRUSES FROM cDNA |
08/05/1992 | EP0496794A1 Non-infectious hiv-1 particles and uses therefor |
08/04/1992 | US5135864 Includes lymphadenopathy associated virus; detecting complex formed by retrovirus and antibodies; elisa |
08/04/1992 | US5135855 Rapid, versatile and simple system for expressing genes in eukaryotic cells |
07/29/1992 | EP0496135A2 Cell free marek's disease virus vaccine |
07/29/1992 | EP0495811A1 Production of genetically-engineered vaccines for aids and other retroviral diseases |
07/23/1992 | WO1992012240A1 Interferon sensitive recombinant poxvirus vaccine |
07/23/1992 | WO1992005266A3 Packaging cells |
07/21/1992 | US5132221 Capable of infecting acidophilic heterotropic bacteria such as genus Acidiphilium; used to prevent acid leaching from abandoned tailings piles and coal mines, enhance biomining of valuable metals, desulfurize mined coal |
07/21/1992 | US5132220 More virulent biotype isolated from wild-type virus |
07/18/1992 | CA2100579A1 Cell ablation using trans-splicing ribozymes |
07/15/1992 | EP0494317A1 The retrovirus SIV cpz-ant and its uses |
07/15/1992 | EP0494244A1 Therapeutic ribozyme compositions and expression vectors |
07/15/1992 | EP0494228A1 Ribozymzusammensetzungen und deren verwendung |
07/15/1992 | EP0494158A1 A recombinant birth control vaccine |
07/14/1992 | CA1305081C Recombinant herpes simplex viruses, vaccines and methods |
07/09/1992 | WO1992011359A1 A truncated interleukin-1 receptor gene for the treatment of arthritis |
07/09/1992 | CA2098848A1 Truncated interleukin-1 receptor gene for the treatment of arthritis |
07/09/1992 | CA2033957A1 Vertebrate poxvirus expression vector under the control of entomopoxvirus spheroidin gene promoter |
07/08/1992 | EP0493575A1 Rotavirus reassortant vaccine |
07/07/1992 | US5128129 Infectious bovine rhinotrachetis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same |
07/07/1992 | US5128128 Virus vaccine |